The report provides an overview of the MedTech Sector, key analytics on M&A transactions announced or closed in 2012 and detailed analyses of deals announced or closed in the fourth quarter.
Tarrytown, New York (PRWEB) February 21, 2013
The Walden Group©, a leading healthcare investment banking firm specializing in mergers and acquisitions, announced the release of its 2012 Annual Strategic Healthcare M&A Report. The report provides an overview of the MedTech Sector, key analytics on M&A transactions announced or closed in 2012 and detailed analyses of deals announced or closed in the fourth quarter. Subscribed to by over 5,000 industry executives, the Report is available on a quarterly basis by emailing The Walden Group at office(at)waldenmed(dot)com or by filling out the online subscription form on its website.
Highlights of the Report include:
- The State of the MedTech Sector
- Valuation and Performance Metrics of Leading Healthcare Companies
- Notable Deals in Q4 2012 -- Summaries
- Top Deals of 2012 > $100m in Transaction Value
- Analysis of more than 85 M&A Transactions announced or closed in Q4 2012
The Walden Group is a special healthcare investment banking firm, offering sophisticated M&A and other investment banking services with a hands-on, customized, operations-oriented approach, based on extensive industry relationships worldwide and a track record of over 20 years. The firm also provides pragmatic strategic consulting services by principals who were healthcare executives at major firms. The firm has lengthy track record of completed transactions spanning multiple clinical areas.
For further information about The Walden Group, please call 914.332.9700 or visit http://www.waldenmed.com.